Related Experiment Video
Updated: Jan 7, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Burden of comorbidities in people with multiple sclerosis: a population-based study in Catalonia
1School of Economics & Social Sciences, Universitat Internacional de Catalunya, Barcelona, Spain.
Insights
People with multiple sclerosis (MS) experience a significant burden of comorbidities early in life. This highlights the need for integrated, lifelong care to manage these complex health conditions effectively.
Area of Science:
- Neurology
- Epidemiology
- Public Health
Background:
- Multiple sclerosis (MS) patients frequently have chronic comorbidities impacting care and prognosis.
- Limited population-based data exists for MS comorbidities in Europe.
Purpose of the Study:
- To determine the prevalence of specific comorbidities in individuals with MS in Catalonia, Spain.
- Utilize administrative health records for comprehensive comorbidity analysis.
Main Methods:
- Analysis of 9,998 individuals diagnosed with MS between 2013 and 2017.
- Stratification of comorbidity prevalence by age and sex, comparing with the general population where possible.
Main Results:
- MS patients exhibited higher rates of psychiatric, metabolic, and autoimmune comorbidities across all age groups.
- Young women (18-40) showed increased depression, anxiety, thyroid disease, and migraine.
- Middle-aged men (50-60) had higher rates of hypertension, hyperlipidemia, and diabetes.
Conclusions:
- Multiple sclerosis is linked to a considerable early-onset comorbidity burden.
- Emphasizes the necessity of integrated, multidisciplinary care throughout the lifespan for MS patients.
Background:
People with multiple sclerosis (MS) often present with chronic comorbidities that complicate care and affect prognosis. Population-based evidence in Europe is limited.
Objective:
To describe the prevalence of selected comorbidities among individuals with MS in Catalonia, Spain, using administrative health records.
Methods:
We analysed data from 9,998 people diagnosed with MS (2013-2017), including demographic and diagnostic information across all care levels. Prevalence estimates for 23 comorbidities were stratified by age and sex, and, where available, compared with those of the general population.
Results:
The MS population had a higher prevalence of psychiatric, metabolic, and autoimmune comorbidities in all age groups. Young women (18-40 years) showed increased rates of depression, anxiety, thyroid disease, and migraine, while middle-aged men (50-60 years) had higher rates of hypertension, hyperlipidaemia, and diabetes.
Conclusion:
MS is associated with a substantial, early-onset comorbidity burden, underscoring the need for integrated, multidisciplinary care across the life course.
Related Concept Videos
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Factors Affecting Illness
For instance, risk factors are connected to illness,...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

